Charles River Laboratories International Inc Quick Ratio (CRL) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Charles River Laboratories International Inc 's Quick Ratio

CRL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.17 a new company low.

Within Medical Laboratories industry 31 other companies have achieved higher Quick Ratio than Charles River Laboratories International Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3141 to 3491.

Explain Quick Ratio?
How much Cash & cash equivalents CRL´s has?
What are CRL´s Current Liabilities?




CRL Quick Ratio (Jun 27 2026)
Q2
(Mar 28 2026)
Q1
(Dec 27 2025)
Q4
(Sep 27 2025)
Q3
(Jun 28 2025)
Q2
Y / Y Current Liabilities Change 39.73 % 12.34 % 27.24 % 16.3 % 15.96 %
Y / Y Cash & cash equivalent Change 5.03 % -16.36 % 9.85 % -1.46 % 2.01 %
Quick Ratio MRQ 0.17 0.21 0.23 0.23 0.23
CRL's Total Ranking # 3491 # 3141 # 1015 # 2609 # 2408
Seq. Current Liabilities Change 26.17 % -5.22 % 7.32 % 8.87 % 1.44 %
Seq. Cash & cash equivalent Change 0.1 % -10.26 % 3.22 % 13.28 % -20.29 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 32
Healthcare Sector # 830
Overall Market # 3491


Quick Ratio Statistics
High Average Low
1.23 0.41 0.17
(Jun 26 2010)   (Jun 27 2026)




Financial Statements
Charles River Laboratories International Inc 's Current Liabilities $ 1,135 Millions Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Cash & cash equivalent $ 192 Millions Visit CRL's Balance sheet
Source of CRL's Sales Visit CRL's Sales by Geography


Cumulative Charles River Laboratories International Inc 's Quick Ratio

CRL's Quick Ratio for the trailling 12 Months

CRL Quick Ratio

(Jun 27 2026)
12 Months
(Mar 28 2026)
12 Months
(Dec 27 2025)
12 Months
(Sep 27 2025)
12 Months
(Jun 28 2025)
12 Months
Y / Y Current Liabilities TTM Growth 24 % 17.88 % 18.62 % 8.27 % 4.72 %
Y / Y Cash & cash equivalent TTM Growth -1.5 % -2.19 % -8.56 % -18.05 % -13.11 %
Quick Ratio TTM 0.21 0.22 0.24 0.25 0.26
Total Ranking TTM # 4094 # 4098 # 2525 # 3277 # 3125
Seq. Current Liabilities TTM Growth 9.1 % 2.87 % 6.26 % 3.97 % 3.72 %
Seq. Cash & cash equivalent TTM Growth 1.16 % -4.5 % 2.35 % -0.38 % 0.44 %


On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2026 to $1,134.75 millions, cumulative Quick Ratio decreased to 0.21 below the Charles River Laboratories International Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Charles River Laboratories International Inc . While Quick Ratio overall ranking has improved so far to 4094, from total ranking during the twelve months ending first quarter 2026 at 4098.

Explain Quick Ratio?
How much Cash & cash equivalents CRL´s has?
What are CRL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 37
Healthcare Sector # 909
Within the Market # 4094


trailing twelve months Quick Ratio Statistics
High Average Low
0.6 0.33 0.18
(Mar 29 2014)   (Jun 27 2026)




Companies with similar Quick Ratio in the quarter ending Jun 27 2026, within Medical Laboratories Industry Quick RatioJun 27 2026 MRQ Cash & cash equivalentJun 27 2026 MRQ Current Liabilities
Ispecimen inc   0.43 $ 4.426  Millions$ 10.196  Millions
Quest Diagnostics Inc  0.40 $ 720.000  Millions$ 1,788.000  Millions
Lumexa Imaging Holdings Inc   0.39 $ 69.705  Millions$ 178.355  Millions
Medpace Holdings Inc   0.35 $ 502.688  Millions$ 1,435.429  Millions
American Shared Hospital Services  0.30 $ 6.761  Millions$ 22.424  Millions
Nuo Therapeutics, Inc.  0.29 $ 0.449  Millions$ 1.554  Millions
Icon Plc  0.24 $ 930.885  Millions$ 3,934.665  Millions
Fortrea Holdings Inc   0.17 $ 168.600  Millions$ 963.700  Millions
Charles River Laboratories International inc   0.17 $ 192.025  Millions$ 1,134.746  Millions
Nrc Health  0.10 $ 3.327  Millions$ 35.019  Millions
Onemednet Corporation  0.07 $ 0.358  Millions$ 4.858  Millions
Labcorp Holdings Inc   0.07 $ 141.800  Millions$ 2,124.600  Millions
First Choice Healthcare Solutions Inc   0.04 $ 0.435  Millions$ 10.085  Millions

Date modified: 2026-09-26T06:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.